Funder: Columbia University
Due Dates: November 24, 2026 (Application deadline, 11:59 PM ET)
Funding Amounts: Up to $50,000 for June 1, 2027–May 31, 2028; up to eight awards expected
Summary: Supports innovations that overcome common research barriers and improve translational research across diseases and fields.
Key Information: Principal investigators must hold a Columbia University faculty appointment at assistant professor level or higher.
Description
The Translational Science Pilot Award is administered by the Irving Institute for Clinical and Translational Research’s Pilot Program at Columbia University. It supports innovative projects that address common scientific and operational roadblocks, improving the efficiency and effectiveness of research and accelerating discoveries into improved human health. Work may span basic science, clinical implementation, and community and public health delivery and scale-up.
The focus is on improving the research process itself, rather than solely advancing an intervention for one disease. Disease-specific projects are welcome when they address a broader translational need and generate knowledge, methods, or tools relevant beyond that disease. Proposals must test an innovation or mitigate a barrier, evaluate its effectiveness, and produce a generalizable deliverable such as a playbook, toolkit, method, or software.
